These results demonstrated that NUAK1 promoted the metastasis of ESCC cells through activating JNK/c-Jun/Slug signaling, indicating NUAK1 is a promising therapeutic target for metastatic ESCC. This evidence concerns the gene NUAK1 and esophageal squamous cell carcinoma.